Literature DB >> 10728361

Central role for ornithine decarboxylase in beta-adrenoceptor mediated hypertrophy.

K D Schlüter1, K Frischkopf, M Flesch, S Rosenkranz, G Taimor, H M Piper.   

Abstract

OBJECTIVE: TGF-beta stimulation of cardiac myocytes induces a hypertrophic responsiveness to beta-adrenoceptor stimulation. This study investigates whether this beta-adrenoceptor mediated effect depends on induction of ornithine decarboxylase (ODC).
METHODS: Isolated adult ventricular cardiomyocytes from rats were used as an experimental model. Cells were either cultured in 20% (v/v) FCS to activate autocrine released TGF-beta or used without pre-treatment. The hypertrophic response was characterized by an increased 14C-phenylalanine incorporation, RNA and protein mass or by an increased expression of atrionatriurectic factor and ODC. The results on cell cultures were compared to those achieved by isoprenaline perfused mice hearts from transgenic mice overexpressing TGF-beta 1.
RESULTS: ODC activity and expression increased within 2 h in TGF-beta 1 pre-treated cells under isoprenaline. In the presence of ODC inhibitors (alpha-methylornithine or difluoromethylornithine) this increase remained absent and the increases in 14C-phenylalanine incorporation, protein and RNA mass under isoprenaline were abolished. In cells not exposed to TGF-beta no induction of ODC was observed. Isoprenaline also induced ODC in isolated perfused ventricles from transgenic mice overexpressing TGF-beta 1, but not in ventricles from their nontransgenic counterparts.
CONCLUSIONS: This study shows first, a pivotal role for ODC induction in the hypertrophic response of cardiomyocytes to beta-adrenoceptor stimulation and second, that ODC induction in vivo and in vitro requires pre-treatment of cardiomyocytes with TGF-beta. It is concluded that TGF-beta induces a hypertrophic responsiveness to beta-adrenoceptor stimulation that is characterized by ODC induction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10728361     DOI: 10.1016/s0008-6363(99)00351-x

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  14 in total

1.  Targeted overexpression of ornithine decarboxylase enhances beta-adrenergic agonist-induced cardiac hypertrophy.

Authors:  L M Shantz; D J Feith; A E Pegg
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

2.  Extracellular matrix remodelling in myocardial hypertrophy and failure : focus on osteopontin.

Authors:  Pietro Francia; Arianna Uccellini; Alessandra Frattari; Anna Modestino; Agnese Ricotta; Cristina Balla; Ludovica Scialla; Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-01-03

3.  Critical factors determining dimerization of human antizyme inhibitor.

Authors:  Kuo-Liang Su; Ya-Fan Liao; Hui-Chih Hung; Guang-Yaw Liu
Journal:  J Biol Chem       Date:  2009-07-27       Impact factor: 5.157

4.  Critical factors governing the difference in antizyme-binding affinities between human ornithine decarboxylase and antizyme inhibitor.

Authors:  Yen-Chin Liu; Yi-Liang Liu; Jia-Yang Su; Guang-Yaw Liu; Hui-Chih Hung
Journal:  PLoS One       Date:  2011-04-28       Impact factor: 3.240

5.  Determinants of the differential antizyme-binding affinity of ornithine decarboxylase.

Authors:  Yen-Chin Liu; Den-Hua Hsu; Chi-Liang Huang; Yi-Liang Liu; Guang-Yaw Liu; Hui-Chih Hung
Journal:  PLoS One       Date:  2011-11-03       Impact factor: 3.240

6.  Transforming growth factor β₁ oppositely regulates the hypertrophic and contractile response to β-adrenergic stimulation in the heart.

Authors:  Michael Huntgeburth; Klaus Tiemann; Robert Shahverdyan; Klaus-Dieter Schlüter; Rolf Schreckenberg; Marie-Luise Gross; Sonja Mödersheim; Evren Caglayan; Jochen Müller-Ehmsen; Alexander Ghanem; Marius Vantler; Wolfram H Zimmermann; Michael Böhm; Stephan Rosenkranz
Journal:  PLoS One       Date:  2011-11-17       Impact factor: 3.240

Review 7.  Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects.

Authors:  Oleg E Osadchii
Journal:  Heart Fail Rev       Date:  2007-03-27       Impact factor: 4.654

8.  Adaptations to iron deficiency: cardiac functional responsiveness to norepinephrine, arterial remodeling, and the effect of beta-blockade on cardiac hypertrophy.

Authors:  Lexa Rae Turner; Daniel Aaron Premo; Brett Jason Gibbs; Megan Lesley Hearthway; Madelyne Motsko; Andrea Sappington; LeeAnn Walker; Michael Eugene Mullendore; Herbert George Chew
Journal:  BMC Physiol       Date:  2002-01-09

Review 9.  Arginase induction and activation during ischemia and reperfusion and functional consequences for the heart.

Authors:  Klaus-Dieter Schlüter; Rainer Schulz; Rolf Schreckenberg
Journal:  Front Physiol       Date:  2015-03-11       Impact factor: 4.566

10.  TSC-22 up-regulates collagen 3a1 gene expression in the rat heart.

Authors:  Annina Kelloniemi; Jani Aro; Juha Näpänkangas; Elina Koivisto; Erja Mustonen; Heikki Ruskoaho; Jaana Rysä
Journal:  BMC Cardiovasc Disord       Date:  2015-10-13       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.